Mesa Laboratories, Inc. (MLAB) Stock Forecast & Price Target
Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Mesa Laboratories, Inc. (MLAB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Mesa Laboratories, Inc., analysts forecast revenue rising from $212.80M in 2024 to $276.69M in 2029; the average estimate for 2029 earnings per share is $0.00; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Mesa Laboratories, Inc. (MLAB) forecast — frequently asked questions
What is the analyst price target for Mesa Laboratories, Inc.?
Analysts covering Mesa Laboratories, Inc. (MLAB) have a consensus price target of $110.00, 19.0% below the current price of $135.84. Published targets range from $110.00 to $110.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Mesa Laboratories, Inc.'s earnings?
The average analyst estimate for Mesa Laboratories, Inc. (MLAB) earnings per share in 2029 is 0.00, with individual estimates between 0.00 and 0.00.
How much revenue is Mesa Laboratories, Inc. expected to make?
Analysts forecast Mesa Laboratories, Inc. (MLAB) revenue of $276.69M in 2029, based on 1 published estimates.
How many analysts cover MLAB?
2 analysts contribute estimates for Mesa Laboratories, Inc. (MLAB). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Specialties stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.